Skoropad, V. Y., Afanasyev, S. G., Gamayunov, S. V., Silanteva, N. K., Agababyan, T. A., Sokolov, P. V., . . . Kaprin, A. D. (2020). PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER. Russian Academy of Sciences, Tomsk National Research Medical Center.
Chicago Style (17th ed.) CitationSkoropad, V. Yu., S. G. Afanasyev, S. V. Gamayunov, N. K. Silanteva, T. A. Agababyan, P. V. Sokolov, S. A. Ivanov, and A. D. Kaprin. PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER. Russian Academy of Sciences, Tomsk National Research Medical Center, 2020.
MLA (9th ed.) CitationSkoropad, V. Yu., et al. PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER. Russian Academy of Sciences, Tomsk National Research Medical Center, 2020.